|
[1]LAFARP KJ,DEMIRJIAN AN,PAWLIK TM.Epidemiology of hepatocellular carcinoma[J].Surg Oncol Clin N Am,2015,24(1):1-17.
|
|
[2]SIEGEL RL,MILLER KD,JEMAL A.Cancer statistics,2015[J].CA Cancer J Clin,2015,65(1):5-29.
|
|
[3]POZZAN C,CARDIN R,PICIOCCHI M,et al.Diagnostic and prognostic role of SCCA-Ig M serum levels in hepatocellular carcinoma(HCC)[J].J Gastroenterol Hepatol,2014,29(8):1637-1644.
|
|
[4]FOMER A,DIAZ-GONZALEZ A,LICCIONI A,et al.Prognosis prediction and staging[J].Best Pract Res Clin Gastroenterol,2014,28(5):855-865.
|
|
[5]MA DQ,CUI H.Research advances in miRNA transfection in vivo[J].J Clin Exp Med,2014,13(21):1825-1829.(in Chinese)马东青,崔红.miRNA体内转染的研究进展[J].临床和实验医学杂志,2014,13(21):1825-1829.
|
|
[6]HA M,KIM VN.Regulation of microRNA biogenesis[J].Nat Rev Mol Cell Biol,2014,15(8):509-524.
|
|
[7]POGRIBNY IP,RUSYN I.Role of epigenetic aberrations in the development and progression of human hepatocellular carcinoma[J].Cancer Lett,2014,342(2):223-230.
|
|
[8]YANG N,EKANEM NR,SAKYI CA,et al.Hepatocellular carcinoma and microRNA:new perspectives on therapeutics and diagnostics[J].Adv Drug Deliv Rev,2015,81C:62-74.
|
|
[9]ZHU Z,ZHANG X,WANG G,et al.Role of microRNAs in hepatocellular carcinoma[J].Hepat Mon,2014,14(8):e18672.
|
|
[10]CALLEGARI E,GRAMANTIERI L,DOMENICALI M,et al.MicroRNAs in liver cancer:a model for investigating pathogenesis and novel therapeutic approaches[J].Cell Death Differ,2015,22(1):46-57.
|
|
[11]BERTINO G,NERI S,BRUNO CM,et al.Diagnostic and prognostic value of alpha-fetoprotein,des-gamma-carboxy prothrombin and squamous cell carcinoma antigen immunoglobulin M complexes in hepatocellular carcinoma[J].Minerva Med,2011,102(5):363-371.
|
|
[12]FONG ZV,TANABE KK.The clinical management of hepatocellular carcinoma in the United States,Europe,and Asia:a comprehensive and evidence-based comparison and review[J].Cancer,2014,120(18):2824-2838.
|
|
[13]QU KZ,ZHANG K,LI H,et al.Circulating microRNAs as biomarkers for hepatocellular carcinoma[J].J Clin Gastroenterol,2011,45(4):355-360.
|
|
[14]GIRARY BG,EMEKDAS G,TEZCAN S,et al.Profiles of serum microRNAs;miR-125b-5p and miR223-3p serve as novel biomarkers for HBV-positive hepatocellular carcinoma[J].Mol Biol Rep,2014,41(7):4513-4519.
|
|
[15]CARDIN R,PICIOCCHI M,SINIGAGLIA A,et al.Oxidative DNA damage correlates with cell immortalization and mir-92 expression in hepatocellular carcinoma[J].BMC Cancer,2012,12:177.
|
|
[16]YAMAMOTO Y,KOSAKA N,TANAKA M,et al.MicroRNA-500 as a potential diagnostic marker for hepatocellular carcinoma[J].Biomarkers,2009,14(7):529-538.
|
|
[17]BARSHACK I,MEIRI E,ROSENWALD S,et al.Differential diagnosis of hepatocellular carcinoma from metastatic tumors in the liver using microRNA expression[J].Int J Biochem Cell Biol,2010,42(8):1355-1362.
|
|
[18]WONG CC,WONG CM,TUNG EK,et al.The microRNA miR-139 suppresses metastasis and progression of hepatocellular carcinoma by down-regulating Rho-kinase 2[J].Gastroenterology,2011,140(1):322-331.
|
|
[19]AUGELLO C,VAIRA V,CARUSO L,et al.MicroRNA profiling of hepatocarcinogenesis identifies C19MC cluster as a novel prognostic biomarker in hepatocellular carcinoma[J].Liver Int,2012,32(5):772-782.
|
|
[20]YAO M,WANG L,QIU L,et al.Encouraging microRNA-based therapeutic strategies for hepatocellular carcinoma[J].Anticancer Agents Med Chem,2014.[Epub ahead of print]
|
|
[21]CHEN JJ,TANG YS,HUANG SF,et al.HBx protein-induced upregulation of microRNA-221 promotes aberrant proliferation in HBV related hepatocellular carcinoma by targeting estrogen receptor-alpha[J].Oncol Rep,2015,33(2):792-798.
|
|
[22]PARK JK,KOGURE T,NUOVO GJ,et al.MiR-221 silencing blocks hepatocellular carcinoma and promotes survival[J].Cancer Res,2011,71(24):7608-7616.
|
|
[23]CALLEGARI E,ELAMIN BK,GIANNONE F,et al.Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model[J].Hepatology,2012,56(3):1025-1033.
|
|
[24]GREENHILL C.Hepatocellular carcinoma:new insight into angiogenesis in hepatocellular carcinoma:involvement of microRNA-26a[J].Nat Rev Gastroenterol Hepatol,2014,11(1):3.
|
|
[25]NAKAO K,MIYAAKI H,ICHIKAWA T.Antitumor function of microRNA-122 against hepatocellular carcinoma[J].J Gastroenterol,2014,49(4):589-593.
|
|
[26]LU Y,YUE X,CUI Y,et al.MicroRNA-124 suppresses growth of human hepatocellular carcinoma by targeting STAT3[J].Biochem Biophys Res Commun,2013,441(4):873-879.
|
|
[27]BOUCHIE A.First microRNA mimic enters clinic[J].Nat Biotechnol,2013,31(7):577.
|
|
[28]LI X,YANG W,LOU L,et al.MicroRNA:a promising diagnostic biomarker and therapeutic target for hepatocellular carcinoma[J].Dig Dis Sci,2014,59(6):1099-1107.
|
|
[29]HSU SH,YU B,WANG X,et al.Cationic lipid nanoparticles for therapeutic delivery of siRNA and miRNA to murine liver tumor[J].Nanomedicine,2013,9(8):1169-1180.
|
DownLoad: